MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor.
about
Twenty Years on: What Do We Really Know about Ewing Sarcoma and What Is the Path Forward?What Do We Know about the Role of miRNAs in Pediatric Sarcoma?Peripheral primitive neuroectodermal tumor of the kidney in a 51-year-old female following breast cancer: A case report and review of the literatureGrowth-promoting role of the miR-106a~363 cluster in Ewing sarcoma.Prognostic and predictive values of long non-coding RNA LINC00472 in breast cancer.mir-30d Regulates multiple genes in the autophagy pathway and impairs autophagy process in human cancer cells.MicroRNAs in Ewing Sarcoma.Mir-30d increases intracellular survival of Helicobacter pylori through inhibition of autophagy pathway.Overexpression of miR-30a in lung adenocarcinoma A549 cell line inhibits migration and invasion via targeting EYA2Systems biology of Ewing sarcoma: a network model of EWS-FLI1 effect on proliferation and apoptosis.Preclinical Justification of pbi-shRNA EWS/FLI1 Lipoplex (LPX) Treatment for Ewing's Sarcoma.MicroRNA function and dysregulation in bone tumors: the evidence to dateCD99 polymorphisms significantly influence the probability to develop Ewing sarcoma in earlier age and patient disease progression.The role of miR-17-92 in the miRegulatory landscape of Ewing sarcoma.MicroRNA expression and its clinical implications in Ewing's sarcoma.microRNA and Bone Cancer.The putative tumor suppressor microRNA-30a-5p modulates clear cell renal cell carcinoma aggressiveness through repression of ZEB2.MiR-30a regulates the proliferation, migration, and invasion of human osteosarcoma by targeting Runx2.MiR-125b inhibits cell biological progression of Ewing's sarcoma by suppressing the PI3K/Akt signalling pathway.The histone demethylase KDM3A is a microRNA-22-regulated tumor promoter in Ewing Sarcoma.miR-130b directly targets ARHGAP1 to drive activation of a metastatic CDC42-PAK1-AP1 positive feedback loop in Ewing sarcoma.Cell-to-cell heterogeneity of EWSR1-FLI1 activity determines proliferation/migration choices in Ewing sarcoma cells.CD99 regulates neural differentiation of Ewing sarcoma cells through miR-34a-Notch-mediated control of NF-κB signaling.CD99 at the crossroads of physiology and pathology.Serum miR-542-3p as a prognostic biomarker in osteosarcoma.CD99: A Cell Surface Protein with an Oncojanus Role in Tumors.Atypical teratoid/ rhabdoid tumor, an immunohistochemical study of potential diagnostic and prognostic markers.MiR-30a: A Novel Biomarker and Potential Therapeutic Target for Cancer
P2860
Q26782649-6445CC90-F906-47FD-9D6E-08CE6B7F58C5Q26800124-86FCBB54-87F5-47EA-A3A3-4226C77DDFF1Q34582509-A2BB2BD5-7178-49EC-80A3-DFD7179B1941Q34702270-EAC0C0B7-BE1A-4B59-B0EF-65BF40BDA6B2Q35832173-C52A0DB6-342C-43F4-BECB-62042CF6428FQ36625470-71725780-0E37-4AE8-B4A0-FCC29293C56DQ36722134-0BD43AB0-EB45-412A-B9D1-CAFB9AB62179Q36772605-9D47D33B-AB91-40B5-8834-B35E5B428825Q36947128-EE5A5C73-7D79-4339-8FDD-4AA2391361B5Q37236770-CCF5F9E9-68E5-46ED-ADBD-33E467F3DEEAQ37256170-2AC1B747-F1DA-4E67-9C1F-49F3FB8C9A59Q37473350-2E41CDE8-A400-4ED1-B700-DF1A858CA4A6Q37718471-AFA154E5-D9B9-474A-8109-171837827DA9Q38289575-DFA82846-2F4A-459F-A983-E33E7A1D2461Q38296481-ADA96F51-4708-455D-B507-6F3DF0F8D1D4Q38667026-0C39A556-95C8-432C-A966-1EFA10D42177Q38751299-1D607ED9-3501-4ECA-9227-BEF0B619940FQ38829378-C2C9A1CE-E6E5-48D5-B49A-9FFC815A6670Q39024985-9A5D11AA-7223-4FB5-8A5D-1901391CE585Q39041044-647E08D8-2088-4F65-A737-D1BADD0E33FBQ40106559-7D1815C1-413A-4BA0-B589-D12B0215255FQ41224633-302F04D4-01D8-45A8-9D1D-5BB9C2EBF2B6Q42392077-BB8C0A74-A6DD-4A07-AC94-37E4F9EDAA82Q47203268-A11E8F84-9AAB-4F0D-93DF-400349377E2AQ50157992-198D119A-255F-445F-BE7B-D2F80369708AQ52658031-99C5E130-8259-42BF-9877-EA299F208F7BQ53410327-EFD86EAA-BFD8-4FAA-BF9C-EDF25199F46FQ58798691-FCFEAD7C-4C6F-4A6B-965E-68161BCD3FF6
P2860
MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor.
@en
type
label
MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor.
@en
prefLabel
MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor.
@en
P2093
P2860
P356
P1433
P1476
MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor.
@en
P2093
D Bellanger
G-A Franzetti
K Laud-Duval
P2860
P2888
P304
P356
10.1038/ONC.2012.403
P407
P577
2013-08-01T00:00:00Z
P6179
1025907366